VerImmune is developing an innovative and programmable Virus-inspired Particle (ViP) platform that can be used as a delivery system to target and treat numerous diseases. The lead program is an innovative first-in-class oncology therapeutic that redirects pre-existing viral or childhood vaccine immunity to target cancers.